 |
Top 16 Startups creating Artificial organs
Oct 12, 2024 | By Jason Kwon | 28 |
These startups create bioengineered tissues, organ-on-a-chip platforms and 3D bioprinting techniques to revolutionize the field of organ transplantation.
1
Country: France | Funding: €238.1M
The mission of every team member at Carmat is to contribute to the development of innovative artificial organs – the artificial heart today, tomorrow other vital organs – to treat millions of patients affected by advanced disease of these organs and to restore their normal life.
The mission of every team member at Carmat is to contribute to the development of innovative artificial organs – the artificial heart today, tomorrow other vital organs – to treat millions of patients affected by advanced disease of these organs and to restore their normal life.
2
Country: France | Funding: $210M
Tissium invents the next generation of synthetic polymers for tissue reconstruction
Tissium invents the next generation of synthetic polymers for tissue reconstruction
3
Country: USA | Funding: $117.5M
At Organovo, we design and create functional human tissues using our proprietary three-dimensional bioprinting technology. Our goal is to build living human tissues that are proven to function like native tissues. With reproducible 3D tissues that accurately represent human biology, we are enabling ground-breaking therapies by:
At Organovo, we design and create functional human tissues using our proprietary three-dimensional bioprinting technology. Our goal is to build living human tissues that are proven to function like native tissues. With reproducible 3D tissues that accurately represent human biology, we are enabling ground-breaking therapies by:
4
Country: USA | Funding: $101.5M
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. Its platform will enable engineered whole cells (called "satellites") to be implanted into patients to repair or even replace damaged organ tissue.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. Its platform will enable engineered whole cells (called "satellites") to be implanted into patients to repair or even replace damaged organ tissue.
5
Country: USA | Funding: $39.4M
SynCardia Systems is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.
SynCardia Systems is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.
6
Country: USA | Funding: $79.4M
Prellis employs holographic tissue printing technology with rapid fully human antibody discovery, in vitro human disease and ADME/Tox models
Prellis employs holographic tissue printing technology with rapid fully human antibody discovery, in vitro human disease and ADME/Tox models
7
Country: USA | Funding: $53M
BiVACOR is a privately held company founded in 2008. Our staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, we have established a strong collaborative network that extends both nationally and internationally. Our world headquarters is located in Houston, Texas, USA, and our international office is in Brisbane, Australia.
BiVACOR is a privately held company founded in 2008. Our staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, we have established a strong collaborative network that extends both nationally and internationally. Our world headquarters is located in Houston, Texas, USA, and our international office is in Brisbane, Australia.
8
Country: USA | Funding: $40M
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
9
Country: Japan | Funding: $29.8M
We contribute to significant advances in medical treatments through our revolutionary 3D tissue-engineering technology. We successfully developed the BIO 3D PRINTER, Regenova. It is a state-of-the-art robotic system that enables fully automated fabrication of three-dimensional artificial tissues/organs from living cells.
We contribute to significant advances in medical treatments through our revolutionary 3D tissue-engineering technology. We successfully developed the BIO 3D PRINTER, Regenova. It is a state-of-the-art robotic system that enables fully automated fabrication of three-dimensional artificial tissues/organs from living cells.
10
Country: India | Funding: $24.6M
Pandorum Technologies is a biotechnology startup with a distinct synergy of life science and engineering competences focused on tissue engineering. The company uses its proprietary technology platforms to design and manufacture functional, three-dimensional living human tissues; intended for medical research, therapeutic and other applications.
Pandorum Technologies is a biotechnology startup with a distinct synergy of life science and engineering competences focused on tissue engineering. The company uses its proprietary technology platforms to design and manufacture functional, three-dimensional living human tissues; intended for medical research, therapeutic and other applications.
